Evidence map›Paper›PMID 33671549›Full record

ArticleInternational journal of molecular sciences2021

Integrin-Linked Kinase Links Integrin Activation to Invadopodia Function and Invasion via the p(T567)-Ezrin/NHERF1/NHE1 Pathway.

Maria Raffaella Greco, Loredana Moro, Stefania Forciniti, Khalid Alfarouk, Stefania Cannone, Rosa Angela Cardone, Stephan Joel Reshkin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cancer cell extravasation requiresBritish journal of cancer · 2024
    Observational
  5. Article
  6. Review
  7. Article
  8. Osteosarcoma mechanobiology and therapeutic targets.British journal of pharmacology · 2022
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maria Raffaella GrecoDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, 70126 Bari, Italy.
Loredana MoroInstitute of Biomembranes, Bioenergetics, National Research Council, 70126 Bari, Italy.
Stefania ForcinitiDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, 70126 Bari, Italy.ORCID 0000-0001-6719-1591
Khalid AlfaroukAlfarouk Biomedical Research Limited Liability Company, Temple Terrace, FL 33617, USA.ORCID 0000-0001-8656-6117
Stefania CannoneDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, 70126 Bari, Italy.
Rosa Angela CardoneDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, 70126 Bari, Italy.ORCID 0000-0002-2011-9135
Stephan Joel ReshkinDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, 70126 Bari, Italy.ORCID 0000-0001-9757-5908
University of Bari Aldo Moro · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 11348Progetti di Rilevanza Nazionale (PRIN) 2009 N.1341Progetti di Rilevanza Nazionale (PRIN) 2017 N.20174TB8KW
6 · The paper itself

Abstract

Tumor cell invasion depends largely on degradation of the extracellular matrix (ECM) by protease-rich structures called invadopodia, whose formation and activity requires the convergence of signaling pathways engaged in cell adhesion, actin assembly, membrane regulation and ECM proteolysis. It is known that β1-integrin stimulates invadopodia function through an invadopodial p(T567)-ezrin/NHERF1/NHE1 signal complex that regulates NHE1-driven invadopodia proteolytic activity and invasion. However, the link between β1-integrin and this signaling complex is unknown. In this study, in metastatic breast (MDA-MB-231) and prostate (PC-3) cancer cells, we report that integrin-linked kinase (ILK) integrates β1-integrin with this signaling complex to regulate invadopodia activity and invasion. Proximity ligation assay experiments demonstrate that, in invadopodia, ILK associates with β1-integrin, NHE1 and the scaffold proteins p(T567)-ezrin and NHERF1. Activation of β1-integrin increased both invasion and invadopodia activity, which were specifically blocked by inhibition of either NHE1 or ILK. We conclude that ILK integrates β1-integrin with the ECM proteolytic/invasion signal module to induce NHE1-driven invadopodial ECM proteolysis and cell invasion.

Indexed as

Cell Line, TumorCytoskeletal ProteinsExtracellular MatrixEzrinHumansIntegrin beta1MalePC-3 CellsPhosphoproteinsPodosomesProtein Serine-Threonine KinasesScaffold Protein ILKSodium-Hydrogen Exchanger 1Sodium-Hydrogen ExchangersCytoskeletal ProteinsEzrinIntegrin beta1Itgb1 protein, humanPhosphoproteinsProtein Serine-Threonine KinasesScaffold Protein ILKSLC9A1 protein, humanSodium-Hydrogen Exchanger 1sodium-hydrogen exchanger regulatory factorSodium-Hydrogen Exchangersbreast cancerintegrin signalinginvadopodiainvasionpHprostate cancer

Identifiers

PMID33671549
PMCPMC7926356
OpenAlexW3131441563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.